Inventor
KATDARE ASHOK V
22 patents
Patents
22 patentsUS5853759ADec 29, 1998
Effervescent alendronate formulation
MERCK & CO INC59 citations96
US5358941AOct 25, 1994
Dry mix formulation for bisphosphonic acids with lactose
MERCK & CO INC95 citations96
US5882656AMar 16, 1999
Dry mix formulation for bisphosphonic acids
MERCK & CO INC69 citations95
US5681590AOct 28, 1997
Dry mix formulation for bisphosphonic acids
MERCK & CO INC50 citations95
US6623755B2Sep 23, 2003
Pharmaceutical tablets
MERCK & CO INC53 citations94
US6692764B2Feb 17, 2004
Wet granulation formulation for bisphosphonic acids
MERCK & CO INC21 citations92
US6090410AJul 18, 2000
Dry mix formulation for bisphosphonic acids
MERCK & CO INC21 citations92
USD400672SNov 3, 1998
Pharmaceutical tablet
MERCK & CO INC23 citations92
USD379223SMay 13, 1997
Pharmaceutical tablet
MERCK & CO INC27 citations92
USD375157SOct 29, 1996
Tablet
MERCK & CO INC27 citations92
US5462932AOct 31, 1995
Oral liquid alendronate formulations
MERCK & CO INC102 citations92
USD431076SSep 19, 2000
Tablet
MERCK & CO INC25 citations90
USD430285SAug 29, 2000
Tablet
MERCK & CO INC30 citations90
US7060294B2Jun 13, 2006
Compressed tablet formulation
MERCK & CO INC37 citations88
US4898736AFeb 6, 1990
Method for tablet preparation
MERCK & CO INC19 citations82
US4639458AJan 27, 1987
Tablet and formulation
MERCK & CO INC22 citations82
US6194004B1Feb 27, 2001
Dry mix formulation for bisphosphonic acids
MERCK & CO INC13 citations81
US6406714B1Jun 18, 2002
Dry mix formulation for bisphosphonic acids
MERCK & CO INC5 citations73
US4910022AMar 20, 1990
Phthalazineacetic acid composition and tablet
MERCK & CO INC8 citations66
US6517867B2Feb 11, 2003
Dry mix formulation for bisphosphonic acids
MERCK & CO INC2 citations62
US6645961B1Nov 11, 2003
Dry granulation formulation for an HIV protease inhibitor
MERCK & CO INC2 citations60
US7595063B2Sep 29, 2009
Compressed tablet formulation
MERCK & CO INC0 citations48